Ross Vickery

Ross Vickery has extensive work experience in the biopharmaceutical industry. Ross currently holds the position of Vice President Clinical Sciences at Theravance Biopharma US, Inc., a role they began in December 2022. Prior to this, their most recent role was as Senior Director Global Clinical Development at Gilead Sciences from March 2022 to December 2022. Before joining Gilead Sciences, Ross held various roles at Theravance Biopharma US, Inc., including Ampreloxetine Project Team Leader, Senior Director Clinical Development, Director Clinical Development, Associate Director Clinical Development, Associate Director Clinical Pharmacology, and Research and Development Scientist. Ross also has experience as a Postdoctoral Fellow at the University of California at San Francisco and as a Graduate Student at Stanford University.

Ross Vickery earned a B.S. degree in Biology from Stanford University in 1984. Ross later pursued a Ph.D. in Molecular and Cellular Physiology at Stanford University School of Medicine, completing their education in 1996.